Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Comment on: Evidence of innate lymphoid cell redundancy in humans.

Orange JS, Mace EM, French AR, Yokoyama WM, Fehniger TA, Cooper MA.

Nat Immunol. 2018 Aug;19(8):788-789. doi: 10.1038/s41590-018-0164-5. No abstract available.

PMID:
30026477
2.

Cross-priming induces immunodomination in the presence of viral MHC class I inhibition.

Lauron EJ, Yang L, Elliott JI, Gainey MD, Fremont DH, Yokoyama WM.

PLoS Pathog. 2018 Feb 14;14(2):e1006883. doi: 10.1371/journal.ppat.1006883. eCollection 2018 Feb.

3.

CD8+ T Cells Prevent Lethality from Neonatal Murine Roseolovirus Infection.

Patel SJ, Yokoyama WM.

J Immunol. 2017 Nov 1;199(9):3212-3221. doi: 10.4049/jimmunol.1700982. Epub 2017 Oct 2.

PMID:
28972091
4.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Sep 19;47(3):597. doi: 10.1016/j.immuni.2017.08.018. No abstract available.

5.

Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.

Bern MD, Beckman DL, Ebihara T, Taffner SM, Poursine-Laurent J, White JM, Yokoyama WM.

Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8440-E8447. doi: 10.1073/pnas.1713064114. Epub 2017 Sep 18.

6.

Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.

Almishaal AA, Mathur PD, Hillas E, Chen L, Zhang A, Yang J, Wang Y, Yokoyama WM, Firpo MA, Park AH.

PLoS Pathog. 2017 Aug 31;13(8):e1006599. doi: 10.1371/journal.ppat.1006599. eCollection 2017 Aug.

7.

Reply to "Murine Roseolovirus, Historically Known as Murine Thymic Lymphotropic Virus".

Patel SJ, Yokoyama WM.

J Virol. 2017 Aug 24;91(18). pii: e00956-17. doi: 10.1128/JVI.00956-17. Print 2017 Sep 15. No abstract available.

8.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Aug 15;47(2):323-338.e6. doi: 10.1016/j.immuni.2017.07.014. Erratum in: Immunity. 2017 Sep 19;47(3):597.

9.

Contribution of inhibitory receptor TIGIT to NK cell education.

He Y, Peng H, Sun R, Wei H, Ljunggren HG, Yokoyama WM, Tian Z.

J Autoimmun. 2017 Jul;81:1-12. doi: 10.1016/j.jaut.2017.04.001. Epub 2017 Apr 21.

PMID:
28438433
10.

A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell Depletion.

Patel SJ, Zhao G, Penna VR, Park E, Lauron EJ, Harvey IB, Beatty WL, Plougastel-Douglas B, Poursine-Laurent J, Fremont DH, Wang D, Yokoyama WM.

J Virol. 2017 Apr 13;91(9). pii: e02463-16. doi: 10.1128/JVI.02463-16. Print 2017 May 1.

11.

Cutting Edge: Human CD49e- NK Cells Are Tissue Resident in the Liver.

Aw Yeang HX, Piersma SJ, Lin Y, Yang L, Malkova ON, Miner C, Krupnick AS, Chapman WC, Yokoyama WM.

J Immunol. 2017 Feb 15;198(4):1417-1422. doi: 10.4049/jimmunol.1601818. Epub 2017 Jan 16.

12.

Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis.

Demehri S, Cunningham TJ, Manivasagam S, Ngo KH, Moradi Tuchayi S, Reddy R, Meyers MA, DeNardo DG, Yokoyama WM.

J Clin Invest. 2016 Apr 1;126(4):1458-70. doi: 10.1172/JCI83724. Epub 2016 Feb 29.

13.

Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells.

Parikh BA, Piersma SJ, Pak-Wittel MA, Yang L, Schreiber RD, Yokoyama WM.

PLoS Pathog. 2015 Dec 31;11(12):e1005323. doi: 10.1371/journal.ppat.1005323. eCollection 2015 Dec.

14.

The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection.

Rapaport AS, Schriewer J, Gilfillan S, Hembrador E, Crump R, Plougastel BF, Wang Y, Le Friec G, Gao J, Cella M, Pircher H, Yokoyama WM, Buller RM, Colonna M.

Immunity. 2015 Dec 15;43(6):1112-24. doi: 10.1016/j.immuni.2015.11.005. Epub 2015 Dec 8.

15.

Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody.

Victorino F, Sojka DK, Brodsky KS, McNamee EN, Masterson JC, Homann D, Yokoyama WM, Eltzschig HK, Clambey ET.

J Immunol. 2015 Nov 15;195(10):4973-85. doi: 10.4049/jimmunol.1500651. Epub 2015 Oct 9.

16.

Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.

Tang L, Peng H, Zhou J, Chen Y, Wei H, Sun R, Yokoyama WM, Tian Z.

J Autoimmun. 2016 Feb;67:29-35. doi: 10.1016/j.jaut.2015.09.004. Epub 2015 Sep 28.

PMID:
26422992
17.

Runx3 specifies lineage commitment of innate lymphoid cells.

Ebihara T, Song C, Ryu SH, Plougastel-Douglas B, Yang L, Levanon D, Groner Y, Bern MD, Stappenbeck TS, Colonna M, Egawa T, Yokoyama WM.

Nat Immunol. 2015 Nov;16(11):1124-33. doi: 10.1038/ni.3272. Epub 2015 Sep 28.

18.

The pancreas anatomy conditions the origin and properties of resident macrophages.

Calderon B, Carrero JA, Ferris ST, Sojka DK, Moore L, Epelman S, Murphy KM, Yokoyama WM, Randolph GJ, Unanue ER.

J Exp Med. 2015 Sep 21;212(10):1497-512. doi: 10.1084/jem.20150496. Epub 2015 Sep 7.

19.

Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.

Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14555. Epub 2015 Jul 8. No abstract available.

PMID:
26153856
20.

PTEN regulates natural killer cell trafficking in vivo.

Leong JW, Schneider SE, Sullivan RP, Parikh BA, Anthony BA, Singh A, Jewell BA, Schappe T, Wagner JA, Link DC, Yokoyama WM, Fehniger TA.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E700-9. doi: 10.1073/pnas.1413886112. Epub 2015 Feb 2.

21.

Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis.

Miner JJ, Aw-Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, Kim AHJ, Diamond MS, Lenschow DJ, Yokoyama WM.

Arthritis Rheumatol. 2015 May;67(5):1214-1220. doi: 10.1002/art.39027.

22.

Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing.

Parikh BA, Beckman DL, Patel SJ, White JM, Yokoyama WM.

PLoS One. 2015 Jan 14;10(1):e0116484. doi: 10.1371/journal.pone.0116484. eCollection 2015.

23.

Chronic allergic contact dermatitis promotes skin cancer.

Demehri S, Cunningham TJ, Hurst EA, Schaffer A, Sheinbein DM, Yokoyama WM.

J Clin Invest. 2014 Nov;124(11):5037-41. doi: 10.1172/JCI77843. Epub 2014 Oct 8.

24.

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells.

Sojka DK, Plougastel-Douglas B, Yang L, Pak-Wittel MA, Artyomov MN, Ivanova Y, Zhong C, Chase JM, Rothman PB, Yu J, Riley JK, Zhu J, Tian Z, Yokoyama WM.

Elife. 2014 Jan 1;3:e01659. doi: 10.7554/eLife.01659.

25.

Isolation of murine natural killer cells.

Pak-Wittel MA, Piersma SJ, Plougastel BF, Poursine-Laurent J, Yokoyama WM.

Curr Protoc Immunol. 2014 Apr 2;105:3.22.1-9. doi: 10.1002/0471142735.im0322s105. Review.

PMID:
24700324
26.

Tissue-resident natural killer cells.

Yokoyama WM, Sojka DK, Peng H, Tian Z.

Cold Spring Harb Symp Quant Biol. 2013;78:149-56. doi: 10.1101/sqb.2013.78.020354. Epub 2014 Feb 28.

PMID:
24584057
27.

Tissue-resident natural killer cells and their potential diversity.

Sojka DK, Tian Z, Yokoyama WM.

Semin Immunol. 2014 Apr;26(2):127-31. doi: 10.1016/j.smim.2014.01.010. Epub 2014 Feb 16. Review.

28.

Production of monoclonal antibodies.

Yokoyama WM, Christensen M, Dos Santos G, Miller D, Ho J, Wu T, Dziegelewski M, Neethling FA.

Curr Protoc Immunol. 2013 Oct 1;102:Unit 2.5.. doi: 10.1002/0471142735.im0205s102.

PMID:
24510488
29.

Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.

Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, Yokoyama WM, Unanue ER, Colonna M, Randolph GJ, Mann DL.

Immunity. 2014 Jan 16;40(1):91-104. doi: 10.1016/j.immuni.2013.11.019.

30.

Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity.

Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, Mar KB, Richardson RB, Ratushny AV, Litvak V, Dabelic R, Manicassamy B, Aitchison JD, Aderem A, Elliott RM, García-Sastre A, Racaniello V, Snijder EJ, Yokoyama WM, Diamond MS, Virgin HW, Rice CM.

Nature. 2014 Jan 30;505(7485):691-5. doi: 10.1038/nature12862. Epub 2013 Nov 27. Erratum in: Nature. 2015 Sep 3;525(7567):144.

31.

Natural killer cell licensing in mice with inducible expression of MHC class I.

Ebihara T, Jonsson AH, Yokoyama WM.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):E4232-7. doi: 10.1073/pnas.1318255110. Epub 2013 Oct 21.

32.

Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes.

Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE, Ivanov S, Duan Q, Bala S, Condon T, van Rooijen N, Grainger JR, Belkaid Y, Ma'ayan A, Riches DW, Yokoyama WM, Ginhoux F, Henson PM, Randolph GJ.

Immunity. 2013 Sep 19;39(3):599-610. doi: 10.1016/j.immuni.2013.08.007. Epub 2013 Sep 5.

33.

Natural killer cells in human autoimmune disorders.

Fogel LA, Yokoyama WM, French AR.

Arthritis Res Ther. 2013 Jul 11;15(4):216. doi: 10.1186/ar4232. Review.

34.

Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription.

Chapa TJ, Johnson LS, Affolter C, Valentine MC, Fehr AR, Yokoyama WM, Yu D.

J Virol. 2013 Aug;87(16):9135-47. doi: 10.1128/JVI.00688-13. Epub 2013 Jun 12.

35.

Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation.

Keyel PA, Roth R, Yokoyama WM, Heuser JE, Salter RD.

Toxins (Basel). 2013 Jun 6;5(6):1105-18. doi: 10.3390/toxins5061105.

36.

Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Peng H, Jiang X, Chen Y, Sojka DK, Wei H, Gao X, Sun R, Yokoyama WM, Tian Z.

J Clin Invest. 2013 Apr;123(4):1444-56. doi: 10.1172/JCI66381. Epub 2013 Mar 25.

37.

Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation.

McCoy WH 4th, Wang X, Yokoyama WM, Hansen TH, Fremont DH.

Mol Immunol. 2013 Sep;55(2):156-8. doi: 10.1016/j.molimm.2012.11.011. Epub 2013 Jan 10. Review.

38.

Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection.

Pak-Wittel MA, Yang L, Sojka DK, Rivenbark JG, Yokoyama WM.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E50-9. doi: 10.1073/pnas.1220456110. Epub 2012 Dec 17.

39.

Structural mechanism of ER retrieval of MHC class I by cowpox.

McCoy WH 4th, Wang X, Yokoyama WM, Hansen TH, Fremont DH.

PLoS Biol. 2012;10(11):e1001432. doi: 10.1371/journal.pbio.1001432. Epub 2012 Nov 27.

40.

Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling.

Sauer K, Park E, Siegemund S, French AR, Wahle JA, Sternberg L, Rigaud S, Jonsson AH, Yokoyama WM, Huang YH.

Blood. 2013 Jan 10;121(2):286-97. doi: 10.1182/blood-2012-05-429241. Epub 2012 Nov 21.

41.

Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Andrews DM, Sullivan LC, Baschuk N, Chan CJ, Berry R, Cotterell CL, Lin J, Halse H, Watt SV, Poursine-Laurent J, Wang CR, Scalzo AA, Yokoyama WM, Rossjohn J, Brooks AG, Smyth MJ.

Nat Immunol. 2012 Dec;13(12):1171-7. doi: 10.1038/ni.2468. Epub 2012 Nov 11. Erratum in: Nat Immunol. 2013 Apr;14(4):413.

42.

Cryopreservation and thawing of cells.

Yokoyama WM, Thompson ML, Ehrhardt RO.

Curr Protoc Immunol. 2012 Nov;Appendix 3:3G. doi: 10.1002/0471142735.ima03gs99.

PMID:
23129152
43.

Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming.

Gainey MD, Rivenbark JG, Cho H, Yang L, Yokoyama WM.

Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3260-7. doi: 10.1073/pnas.1217111109. Epub 2012 Oct 29.

44.

Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer.

Kreisel D, Gelman AE, Higashikubo R, Lin X, Vikis HG, White JM, Toth KA, Deshpande C, Carreno BM, You M, Taffner SM, Yokoyama WM, Bui JD, Schreiber RD, Krupnick AS.

Cancer Res. 2012 Sep 1;72(17):4311-7. Epub 2012 Jun 29.

45.

2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.

Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M Jr, Virgin HW, Klein RS, Sen GC, Diamond MS.

PLoS Pathog. 2012;8(5):e1002698. doi: 10.1371/journal.ppat.1002698. Epub 2012 May 10.

46.

A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection.

Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS.

PLoS Pathog. 2011 Dec;7(12):e1002407. doi: 10.1371/journal.ppat.1002407. Epub 2011 Dec 1.

47.

Development of thymic NK cells from double negative 1 thymocyte precursors.

Vargas CL, Poursine-Laurent J, Yang L, Yokoyama WM.

Blood. 2011 Sep 29;118(13):3570-8. doi: 10.1182/blood-2011-06-359679. Epub 2011 Aug 5.

48.

Unifying concepts of MHC-dependent natural killer cell education.

Elliott JM, Yokoyama WM.

Trends Immunol. 2011 Aug;32(8):364-72. doi: 10.1016/j.it.2011.06.001. Epub 2011 Jul 13. Review.

49.

Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane.

Keyel PA, Loultcheva L, Roth R, Salter RD, Watkins SC, Yokoyama WM, Heuser JE.

J Cell Sci. 2011 Jul 15;124(Pt 14):2414-23. doi: 10.1242/jcs.076182. Epub 2011 Jun 21.

50.

Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.

Choi T, Ferris ST, Matsumoto N, Poursine-Laurent J, Yokoyama WM.

J Immunol. 2011 Apr 1;186(7):3911-7. doi: 10.4049/jimmunol.1004168. Epub 2011 Feb 18.

Supplemental Content

Loading ...
Support Center